Zhi‐Ming Shao - Concepedia

Author

Zhi‐Ming Shao

Fudan University Shanghai Cancer Center ORCID

Also Known As

Shao, Zhi-Ming, Shiping Li, Xiao-En Xu, Z M Shao, Z Shao, Z. Shao, Z.-M. Shao, Z.M. Shao, Ze-Hua Shao, Ze-hua Shao

356

Publications

12.8K

Citations

H-Index

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Fudan University Shanghai Cancer Institute University of Maryland, Baltimore

About

Zhi‐Ming Shao is an author at Fudan University Shanghai Cancer Center specializing in breast cancer, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	42	7.2K
2	Health Sciences	7	7	4.8K
3	Engineering	3	3	58
4	Natural Sciences	1	1	31
5	Nursing	1	1	3.6K

Zhi‐Ming Shao

109

Publications

11.5K

Citations

H-Index

Page 1

	Year	Citations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Annals of Oncology Surgical OncologyBreast OncologyCancer ManagementPrimary TherapyPathology	2013	3.6K
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer, Annals of Oncology	2017	1.2K
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies Yi-Zhou Jiang, Ding Ma, Chen Suo, Cancer Cell Transcriptomic LandscapeTreatment StrategiesBreast OncologyTriple-negative Breast CancersTumor Heterogeneity	2019	1K
Challenges to effective cancer control in China, India, and Russia Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky, The Lancet Oncology MedicineGlobal HealthCancer ManagementCancer PreventionBreast Cancer	2014	497
Curcumin exerts multiple suppressive effects on human breast carcinoma cells Zhi‐Ming Shao, Zhenzhou Shen, Canhui Liu, International Journal of Cancer Tumor BiologyBreast OncologyOncologyChemoprevention StrategyEndocrine-related Cancer	2001	310
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial Yi-Zhou Jiang, Yin Liu, Yi Xiao, Cell Research	2020	298
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer Yi Xiao, Ding Ma, Yun‐Song Yang, Cell Research	2022	297
LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription Bingqiu Xiu, Yayun Chi, Lei Liu, Molecular Cancer	2019	216
Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value Yi-Zhou Jiang, Yi‐Rong Liu, Xiao‐En Xu, Cancer Research	2016	189
Insulin‐like growth factor‐binding protein enhancement of insulin‐like growth factor‐i (IGF‐I)–mediated DNA synthesis and IGF‐I binding in a human breast carcinoma cell line Jian‐Chyi Chen, Zhi‐Ming Shao, M. Saeed Sheikh, Journal of Cellular Physiology	1994	151

Page 1